Current Report Filing (8-k)
October 12 2018 - 5:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
October 12, 2018
(
October 12,
2018)
Heyu
Biological Technology Corporation
(Exact Name of Registrant as Specified in its
Charter)
Nevada
|
|
000-26731
|
|
87-0627910
|
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification Number)
|
4th Floor, No. 10 Building, Xinglin Bay Business
Operation Center,
Jimei District, Xiamen City,
Fujian Province, China 361022
(Address of Principal Executive Offices, Zip
Code)
Registrant’s telephone number, including
area code:
(86) 158 5924 0902
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Appointment of New Director – Kwee
Huwa Tan
On October 12, 2018, Ms. Kwee Huwa Tan was
appointed to the Board of Directors of the Company to serve as a director of the Company.
Ms. Kwee Huwa Tan, age 54, is a sales &
marketing expert with a strong entrepreneurial spirit. Since April 2017, Ms. Tan has been a director for Heyu Leisure Holidays
Corporation, a U.S. public company managing budget hotels in China. In 2012, Ms. Tan founded Isbel Beauty Centre., a provider of
primer skin care products in Malaysia, and she has been the Chief Executive Officer of Isbel Beauty Centre since 2012. Ms. Tan
has also served as the Chief Advisor to Heyu Biological Technology Corporation (Xiamen) since 2013 where she was tasked with developing
networking opportunities, analyzing profitability of products and market potentials and cultivating prospective clients. Ms. Tan
earned her bachelor degree in Business Administration from Ansted University in Malaysia in 1986.
Ms. Tan does not have any family relationship
with any director or executive officer of the Company and has not been involved in any transaction with the Company during the
past two years that would require disclosure under Item 404(a) of Regulation S-K.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Heyu Biological
Technology Corporation
|
|
|
|
By:
|
/s/
Ban Siong Ang
|
|
Name:
Title:
|
Ban Siong Ang
Chief Executive
Officer
|
|
|
|
|
Date:
|
October 12, 2018
|
|
|
|
Heyu Biological Technology (PK) (USOTC:HYBT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Heyu Biological Technology (PK) (USOTC:HYBT)
Historical Stock Chart
From Sep 2023 to Sep 2024